nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0725	0.216	CbGbCtD
Ipratropium bromide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0549	0.164	CbGbCtD
Ipratropium bromide—CYP3A4—Betamethasone—psoriatic arthritis	0.0471	0.14	CbGbCtD
Ipratropium bromide—CYP3A4—Prednisolone—psoriatic arthritis	0.0465	0.139	CbGbCtD
Ipratropium bromide—CYP3A4—Prednisone—psoriatic arthritis	0.0439	0.131	CbGbCtD
Ipratropium bromide—CYP2D6—Dexamethasone—psoriatic arthritis	0.0431	0.128	CbGbCtD
Ipratropium bromide—CYP3A4—Dexamethasone—psoriatic arthritis	0.0274	0.0817	CbGbCtD
Ipratropium bromide—Epistaxis—Triamcinolone—psoriatic arthritis	0.00195	0.00294	CcSEcCtD
Ipratropium bromide—Visual impairment—Prednisolone—psoriatic arthritis	0.00195	0.00293	CcSEcCtD
Ipratropium bromide—Haemoglobin—Triamcinolone—psoriatic arthritis	0.00187	0.00281	CcSEcCtD
Ipratropium bromide—Haemoglobin—Methylprednisolone—psoriatic arthritis	0.00186	0.00281	CcSEcCtD
Ipratropium bromide—Rhinitis—Triamcinolone—psoriatic arthritis	0.00186	0.0028	CcSEcCtD
Ipratropium bromide—Rhinitis—Methylprednisolone—psoriatic arthritis	0.00186	0.0028	CcSEcCtD
Ipratropium bromide—Haemorrhage—Triamcinolone—psoriatic arthritis	0.00186	0.0028	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methylprednisolone—psoriatic arthritis	0.00185	0.00279	CcSEcCtD
Ipratropium bromide—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00184	0.00278	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00184	0.00277	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00184	0.00277	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.00183	0.00275	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Betamethasone—psoriatic arthritis	0.00183	0.00275	CcSEcCtD
Ipratropium bromide—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00179	0.00269	CcSEcCtD
Ipratropium bromide—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00173	0.00261	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00172	0.00259	CcSEcCtD
Ipratropium bromide—Haemoglobin—Dexamethasone—psoriatic arthritis	0.00169	0.00255	CcSEcCtD
Ipratropium bromide—Haemoglobin—Betamethasone—psoriatic arthritis	0.00169	0.00255	CcSEcCtD
Ipratropium bromide—Haemorrhage—Betamethasone—psoriatic arthritis	0.00169	0.00254	CcSEcCtD
Ipratropium bromide—Haemorrhage—Dexamethasone—psoriatic arthritis	0.00169	0.00254	CcSEcCtD
Ipratropium bromide—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00167	0.00252	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00167	0.00252	CcSEcCtD
Ipratropium bromide—Vision blurred—Prednisolone—psoriatic arthritis	0.00166	0.0025	CcSEcCtD
Ipratropium bromide—Visual impairment—Dexamethasone—psoriatic arthritis	0.00163	0.00245	CcSEcCtD
Ipratropium bromide—Visual impairment—Betamethasone—psoriatic arthritis	0.00163	0.00245	CcSEcCtD
Ipratropium bromide—Angioedema—Prednisolone—psoriatic arthritis	0.00161	0.00242	CcSEcCtD
Ipratropium bromide—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.0016	0.00241	CcSEcCtD
Ipratropium bromide—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00158	0.00238	CcSEcCtD
Ipratropium bromide—Eye disorder—Betamethasone—psoriatic arthritis	0.00158	0.00237	CcSEcCtD
Ipratropium bromide—Eye disorder—Dexamethasone—psoriatic arthritis	0.00158	0.00237	CcSEcCtD
Ipratropium bromide—Back pain—Triamcinolone—psoriatic arthritis	0.00156	0.00236	CcSEcCtD
Ipratropium bromide—Asthma—Methotrexate—psoriatic arthritis	0.00153	0.00231	CcSEcCtD
Ipratropium bromide—Hypertension—Prednisolone—psoriatic arthritis	0.00152	0.00229	CcSEcCtD
Ipratropium bromide—Angioedema—Triamcinolone—psoriatic arthritis	0.00148	0.00223	CcSEcCtD
Ipratropium bromide—Haemoglobin—Prednisone—psoriatic arthritis	0.00148	0.00222	CcSEcCtD
Ipratropium bromide—Angioedema—Methylprednisolone—psoriatic arthritis	0.00147	0.00222	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.00147	0.00221	CcSEcCtD
Ipratropium bromide—Haemorrhage—Prednisone—psoriatic arthritis	0.00147	0.00221	CcSEcCtD
Ipratropium bromide—Oedema—Prednisolone—psoriatic arthritis	0.00144	0.00216	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00144	0.00216	CcSEcCtD
Ipratropium bromide—Dysuria—Methotrexate—psoriatic arthritis	0.00143	0.00216	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00143	0.00214	CcSEcCtD
Ipratropium bromide—Cough—Triamcinolone—psoriatic arthritis	0.00141	0.00212	CcSEcCtD
Ipratropium bromide—Tachycardia—Prednisolone—psoriatic arthritis	0.0014	0.00211	CcSEcCtD
Ipratropium bromide—Hypertension—Triamcinolone—psoriatic arthritis	0.0014	0.0021	CcSEcCtD
Ipratropium bromide—Hypertension—Methylprednisolone—psoriatic arthritis	0.00139	0.0021	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00139	0.00209	CcSEcCtD
Ipratropium bromide—Myalgia—Triamcinolone—psoriatic arthritis	0.00138	0.00207	CcSEcCtD
Ipratropium bromide—Myalgia—Methylprednisolone—psoriatic arthritis	0.00137	0.00207	CcSEcCtD
Ipratropium bromide—Eye disorder—Prednisone—psoriatic arthritis	0.00137	0.00207	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00136	0.00205	CcSEcCtD
Ipratropium bromide—Flushing—Prednisone—psoriatic arthritis	0.00136	0.00205	CcSEcCtD
Ipratropium bromide—Dry mouth—Triamcinolone—psoriatic arthritis	0.00135	0.00203	CcSEcCtD
Ipratropium bromide—Angioedema—Dexamethasone—psoriatic arthritis	0.00134	0.00202	CcSEcCtD
Ipratropium bromide—Angioedema—Betamethasone—psoriatic arthritis	0.00134	0.00202	CcSEcCtD
Ipratropium bromide—Stomatitis—Methotrexate—psoriatic arthritis	0.00133	0.00201	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00133	0.002	CcSEcCtD
Ipratropium bromide—Immune system disorder—Prednisone—psoriatic arthritis	0.00133	0.002	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00132	0.00199	CcSEcCtD
Ipratropium bromide—Oedema—Triamcinolone—psoriatic arthritis	0.00132	0.00199	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00132	0.00198	CcSEcCtD
Ipratropium bromide—Infection—Triamcinolone—psoriatic arthritis	0.00131	0.00197	CcSEcCtD
Ipratropium bromide—Sweating—Methotrexate—psoriatic arthritis	0.00131	0.00197	CcSEcCtD
Ipratropium bromide—Infection—Methylprednisolone—psoriatic arthritis	0.00131	0.00197	CcSEcCtD
Ipratropium bromide—Insomnia—Prednisolone—psoriatic arthritis	0.0013	0.00195	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00129	0.00194	CcSEcCtD
Ipratropium bromide—Epistaxis—Methotrexate—psoriatic arthritis	0.00129	0.00194	CcSEcCtD
Ipratropium bromide—Paraesthesia—Prednisolone—psoriatic arthritis	0.00129	0.00194	CcSEcCtD
Ipratropium bromide—Tachycardia—Triamcinolone—psoriatic arthritis	0.00129	0.00194	CcSEcCtD
Ipratropium bromide—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00129	0.00194	CcSEcCtD
Ipratropium bromide—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00128	0.00193	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00128	0.00192	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00127	0.00192	CcSEcCtD
Ipratropium bromide—Hypertension—Betamethasone—psoriatic arthritis	0.00127	0.00191	CcSEcCtD
Ipratropium bromide—Hypertension—Dexamethasone—psoriatic arthritis	0.00127	0.00191	CcSEcCtD
Ipratropium bromide—Myalgia—Betamethasone—psoriatic arthritis	0.00125	0.00188	CcSEcCtD
Ipratropium bromide—Myalgia—Dexamethasone—psoriatic arthritis	0.00125	0.00188	CcSEcCtD
Ipratropium bromide—Haemoglobin—Methotrexate—psoriatic arthritis	0.00123	0.00186	CcSEcCtD
Ipratropium bromide—Hypotension—Methylprednisolone—psoriatic arthritis	0.00123	0.00185	CcSEcCtD
Ipratropium bromide—Pain—Prednisolone—psoriatic arthritis	0.00123	0.00185	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methotrexate—psoriatic arthritis	0.00123	0.00185	CcSEcCtD
Ipratropium bromide—Pharyngitis—Methotrexate—psoriatic arthritis	0.00122	0.00183	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.00121	0.00182	CcSEcCtD
Ipratropium bromide—Vision blurred—Prednisone—psoriatic arthritis	0.0012	0.00181	CcSEcCtD
Ipratropium bromide—Urethral disorder—Methotrexate—psoriatic arthritis	0.0012	0.00181	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.0012	0.00181	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.0012	0.00181	CcSEcCtD
Ipratropium bromide—Oedema—Betamethasone—psoriatic arthritis	0.0012	0.0018	CcSEcCtD
Ipratropium bromide—Oedema—Dexamethasone—psoriatic arthritis	0.0012	0.0018	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.0012	0.0018	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.0012	0.0018	CcSEcCtD
Ipratropium bromide—Insomnia—Triamcinolone—psoriatic arthritis	0.00119	0.0018	CcSEcCtD
Ipratropium bromide—Insomnia—Methylprednisolone—psoriatic arthritis	0.00119	0.00179	CcSEcCtD
Ipratropium bromide—Infection—Dexamethasone—psoriatic arthritis	0.00119	0.00179	CcSEcCtD
Ipratropium bromide—Infection—Betamethasone—psoriatic arthritis	0.00119	0.00179	CcSEcCtD
Ipratropium bromide—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00119	0.00178	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00118	0.00178	CcSEcCtD
Ipratropium bromide—Visual impairment—Methotrexate—psoriatic arthritis	0.00118	0.00178	CcSEcCtD
Ipratropium bromide—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00118	0.00177	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00117	0.00177	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00117	0.00177	CcSEcCtD
Ipratropium bromide—Tachycardia—Dexamethasone—psoriatic arthritis	0.00117	0.00176	CcSEcCtD
Ipratropium bromide—Tachycardia—Betamethasone—psoriatic arthritis	0.00117	0.00176	CcSEcCtD
Ipratropium bromide—Angioedema—Prednisone—psoriatic arthritis	0.00117	0.00176	CcSEcCtD
Ipratropium bromide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00116	0.00175	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00116	0.00175	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00116	0.00174	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00116	0.00174	CcSEcCtD
Ipratropium bromide—Eye disorder—Methotrexate—psoriatic arthritis	0.00115	0.00173	CcSEcCtD
Ipratropium bromide—Tinnitus—Methotrexate—psoriatic arthritis	0.00114	0.00172	CcSEcCtD
Ipratropium bromide—Urticaria—Prednisolone—psoriatic arthritis	0.00114	0.00172	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methotrexate—psoriatic arthritis	0.00114	0.00171	CcSEcCtD
Ipratropium bromide—Fatigue—Triamcinolone—psoriatic arthritis	0.00114	0.00171	CcSEcCtD
Ipratropium bromide—Fatigue—Methylprednisolone—psoriatic arthritis	0.00114	0.00171	CcSEcCtD
Ipratropium bromide—Pain—Triamcinolone—psoriatic arthritis	0.00113	0.0017	CcSEcCtD
Ipratropium bromide—Hypotension—Dexamethasone—psoriatic arthritis	0.00112	0.00169	CcSEcCtD
Ipratropium bromide—Hypotension—Betamethasone—psoriatic arthritis	0.00112	0.00169	CcSEcCtD
Ipratropium bromide—Immune system disorder—Methotrexate—psoriatic arthritis	0.00111	0.00167	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00111	0.00166	CcSEcCtD
Ipratropium bromide—Hypertension—Prednisone—psoriatic arthritis	0.0011	0.00166	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00109	0.00164	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00109	0.00164	CcSEcCtD
Ipratropium bromide—Myalgia—Prednisone—psoriatic arthritis	0.00109	0.00164	CcSEcCtD
Ipratropium bromide—Insomnia—Dexamethasone—psoriatic arthritis	0.00108	0.00163	CcSEcCtD
Ipratropium bromide—Insomnia—Betamethasone—psoriatic arthritis	0.00108	0.00163	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00108	0.00163	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00108	0.00162	CcSEcCtD
Ipratropium bromide—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00108	0.00162	CcSEcCtD
Ipratropium bromide—Paraesthesia—Betamethasone—psoriatic arthritis	0.00108	0.00162	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00106	0.00159	CcSEcCtD
Ipratropium bromide—Dyspepsia—Betamethasone—psoriatic arthritis	0.00105	0.00159	CcSEcCtD
Ipratropium bromide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00105	0.00159	CcSEcCtD
Ipratropium bromide—Urticaria—Triamcinolone—psoriatic arthritis	0.00105	0.00158	CcSEcCtD
Ipratropium bromide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00105	0.00158	CcSEcCtD
Ipratropium bromide—Dysgeusia—Methotrexate—psoriatic arthritis	0.00105	0.00157	CcSEcCtD
Ipratropium bromide—Oedema—Prednisone—psoriatic arthritis	0.00104	0.00157	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00104	0.00157	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00104	0.00157	CcSEcCtD
Ipratropium bromide—Infection—Prednisone—psoriatic arthritis	0.00104	0.00156	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00103	0.00156	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00103	0.00156	CcSEcCtD
Ipratropium bromide—Back pain—Methotrexate—psoriatic arthritis	0.00103	0.00156	CcSEcCtD
Ipratropium bromide—Fatigue—Dexamethasone—psoriatic arthritis	0.00103	0.00155	CcSEcCtD
Ipratropium bromide—Fatigue—Betamethasone—psoriatic arthritis	0.00103	0.00155	CcSEcCtD
Ipratropium bromide—Pain—Dexamethasone—psoriatic arthritis	0.00102	0.00154	CcSEcCtD
Ipratropium bromide—Pain—Betamethasone—psoriatic arthritis	0.00102	0.00154	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Prednisone—psoriatic arthritis	0.00102	0.00154	CcSEcCtD
Ipratropium bromide—Tachycardia—Prednisone—psoriatic arthritis	0.00102	0.00153	CcSEcCtD
Ipratropium bromide—Skin disorder—Prednisone—psoriatic arthritis	0.00101	0.00153	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00101	0.00152	CcSEcCtD
Ipratropium bromide—Vision blurred—Methotrexate—psoriatic arthritis	0.00101	0.00152	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00098	0.00147	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00098	0.00147	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000973	0.00146	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000971	0.00146	CcSEcCtD
Ipratropium bromide—Urticaria—Dexamethasone—psoriatic arthritis	0.000952	0.00143	CcSEcCtD
Ipratropium bromide—Urticaria—Betamethasone—psoriatic arthritis	0.000952	0.00143	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000951	0.00143	CcSEcCtD
Ipratropium bromide—Dizziness—Prednisolone—psoriatic arthritis	0.000949	0.00143	CcSEcCtD
Ipratropium bromide—Asthenia—Triamcinolone—psoriatic arthritis	0.000947	0.00143	CcSEcCtD
Ipratropium bromide—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000947	0.00143	CcSEcCtD
Ipratropium bromide—Abdominal pain—Betamethasone—psoriatic arthritis	0.000947	0.00143	CcSEcCtD
Ipratropium bromide—Asthenia—Methylprednisolone—psoriatic arthritis	0.000945	0.00142	CcSEcCtD
Ipratropium bromide—Insomnia—Prednisone—psoriatic arthritis	0.000944	0.00142	CcSEcCtD
Ipratropium bromide—Paraesthesia—Prednisone—psoriatic arthritis	0.000937	0.00141	CcSEcCtD
Ipratropium bromide—Pruritus—Triamcinolone—psoriatic arthritis	0.000934	0.00141	CcSEcCtD
Ipratropium bromide—Cough—Methotrexate—psoriatic arthritis	0.000932	0.0014	CcSEcCtD
Ipratropium bromide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000932	0.0014	CcSEcCtD
Ipratropium bromide—Dyspepsia—Prednisone—psoriatic arthritis	0.000918	0.00138	CcSEcCtD
Ipratropium bromide—Chest pain—Methotrexate—psoriatic arthritis	0.00091	0.00137	CcSEcCtD
Ipratropium bromide—Myalgia—Methotrexate—psoriatic arthritis	0.00091	0.00137	CcSEcCtD
Ipratropium bromide—Rash—Prednisolone—psoriatic arthritis	0.000905	0.00136	CcSEcCtD
Ipratropium bromide—Dermatitis—Prednisolone—psoriatic arthritis	0.000904	0.00136	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000903	0.00136	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000901	0.00136	CcSEcCtD
Ipratropium bromide—Fatigue—Prednisone—psoriatic arthritis	0.0009	0.00135	CcSEcCtD
Ipratropium bromide—Headache—Prednisolone—psoriatic arthritis	0.000899	0.00135	CcSEcCtD
Ipratropium bromide—Constipation—Prednisone—psoriatic arthritis	0.000892	0.00134	CcSEcCtD
Ipratropium bromide—Dizziness—Triamcinolone—psoriatic arthritis	0.000873	0.00131	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000872	0.00131	CcSEcCtD
Ipratropium bromide—Dizziness—Methylprednisolone—psoriatic arthritis	0.000871	0.00131	CcSEcCtD
Ipratropium bromide—Infection—Methotrexate—psoriatic arthritis	0.000866	0.0013	CcSEcCtD
Ipratropium bromide—Asthenia—Dexamethasone—psoriatic arthritis	0.00086	0.00129	CcSEcCtD
Ipratropium bromide—Asthenia—Betamethasone—psoriatic arthritis	0.00086	0.00129	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000855	0.00129	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000853	0.00128	CcSEcCtD
Ipratropium bromide—Nausea—Prednisolone—psoriatic arthritis	0.000853	0.00128	CcSEcCtD
Ipratropium bromide—Pruritus—Betamethasone—psoriatic arthritis	0.000848	0.00128	CcSEcCtD
Ipratropium bromide—Pruritus—Dexamethasone—psoriatic arthritis	0.000848	0.00128	CcSEcCtD
Ipratropium bromide—Skin disorder—Methotrexate—psoriatic arthritis	0.000847	0.00127	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000843	0.00127	CcSEcCtD
Ipratropium bromide—Vomiting—Triamcinolone—psoriatic arthritis	0.00084	0.00126	CcSEcCtD
Ipratropium bromide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000838	0.00126	CcSEcCtD
Ipratropium bromide—Rash—Triamcinolone—psoriatic arthritis	0.000833	0.00125	CcSEcCtD
Ipratropium bromide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000832	0.00125	CcSEcCtD
Ipratropium bromide—Rash—Methylprednisolone—psoriatic arthritis	0.000831	0.00125	CcSEcCtD
Ipratropium bromide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00083	0.00125	CcSEcCtD
Ipratropium bromide—Urticaria—Prednisone—psoriatic arthritis	0.000829	0.00125	CcSEcCtD
Ipratropium bromide—Headache—Triamcinolone—psoriatic arthritis	0.000827	0.00125	CcSEcCtD
Ipratropium bromide—Headache—Methylprednisolone—psoriatic arthritis	0.000825	0.00124	CcSEcCtD
Ipratropium bromide—Abdominal pain—Prednisone—psoriatic arthritis	0.000825	0.00124	CcSEcCtD
Ipratropium bromide—Diarrhoea—Betamethasone—psoriatic arthritis	0.00082	0.00123	CcSEcCtD
Ipratropium bromide—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00082	0.00123	CcSEcCtD
Ipratropium bromide—Hypotension—Methotrexate—psoriatic arthritis	0.000815	0.00123	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000794	0.0012	CcSEcCtD
Ipratropium bromide—Dizziness—Dexamethasone—psoriatic arthritis	0.000792	0.00119	CcSEcCtD
Ipratropium bromide—Dizziness—Betamethasone—psoriatic arthritis	0.000792	0.00119	CcSEcCtD
Ipratropium bromide—Insomnia—Methotrexate—psoriatic arthritis	0.000789	0.00119	CcSEcCtD
Ipratropium bromide—Nausea—Triamcinolone—psoriatic arthritis	0.000784	0.00118	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methotrexate—psoriatic arthritis	0.000783	0.00118	CcSEcCtD
Ipratropium bromide—Nausea—Methylprednisolone—psoriatic arthritis	0.000783	0.00118	CcSEcCtD
Ipratropium bromide—Dyspnoea—Methotrexate—psoriatic arthritis	0.000777	0.00117	CcSEcCtD
Ipratropium bromide—Somnolence—Methotrexate—psoriatic arthritis	0.000775	0.00117	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000769	0.00116	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methotrexate—psoriatic arthritis	0.000768	0.00116	CcSEcCtD
Ipratropium bromide—Vomiting—Betamethasone—psoriatic arthritis	0.000762	0.00115	CcSEcCtD
Ipratropium bromide—Vomiting—Dexamethasone—psoriatic arthritis	0.000762	0.00115	CcSEcCtD
Ipratropium bromide—Rash—Dexamethasone—psoriatic arthritis	0.000755	0.00114	CcSEcCtD
Ipratropium bromide—Rash—Betamethasone—psoriatic arthritis	0.000755	0.00114	CcSEcCtD
Ipratropium bromide—Dermatitis—Betamethasone—psoriatic arthritis	0.000755	0.00114	CcSEcCtD
Ipratropium bromide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000755	0.00114	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000753	0.00113	CcSEcCtD
Ipratropium bromide—Fatigue—Methotrexate—psoriatic arthritis	0.000752	0.00113	CcSEcCtD
Ipratropium bromide—Headache—Dexamethasone—psoriatic arthritis	0.000751	0.00113	CcSEcCtD
Ipratropium bromide—Headache—Betamethasone—psoriatic arthritis	0.000751	0.00113	CcSEcCtD
Ipratropium bromide—Asthenia—Prednisone—psoriatic arthritis	0.000749	0.00113	CcSEcCtD
Ipratropium bromide—Pain—Methotrexate—psoriatic arthritis	0.000746	0.00112	CcSEcCtD
Ipratropium bromide—Pruritus—Prednisone—psoriatic arthritis	0.000738	0.00111	CcSEcCtD
Ipratropium bromide—Diarrhoea—Prednisone—psoriatic arthritis	0.000714	0.00107	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000713	0.00107	CcSEcCtD
Ipratropium bromide—Nausea—Betamethasone—psoriatic arthritis	0.000712	0.00107	CcSEcCtD
Ipratropium bromide—Nausea—Dexamethasone—psoriatic arthritis	0.000712	0.00107	CcSEcCtD
Ipratropium bromide—Urticaria—Methotrexate—psoriatic arthritis	0.000693	0.00104	CcSEcCtD
Ipratropium bromide—Dizziness—Prednisone—psoriatic arthritis	0.00069	0.00104	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methotrexate—psoriatic arthritis	0.000689	0.00104	CcSEcCtD
Ipratropium bromide—Vomiting—Prednisone—psoriatic arthritis	0.000663	0.000998	CcSEcCtD
Ipratropium bromide—Rash—Prednisone—psoriatic arthritis	0.000658	0.00099	CcSEcCtD
Ipratropium bromide—Dermatitis—Prednisone—psoriatic arthritis	0.000657	0.000989	CcSEcCtD
Ipratropium bromide—Headache—Prednisone—psoriatic arthritis	0.000654	0.000984	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000642	0.000967	CcSEcCtD
Ipratropium bromide—Asthenia—Methotrexate—psoriatic arthritis	0.000626	0.000942	CcSEcCtD
Ipratropium bromide—Nausea—Prednisone—psoriatic arthritis	0.00062	0.000933	CcSEcCtD
Ipratropium bromide—Pruritus—Methotrexate—psoriatic arthritis	0.000617	0.000929	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methotrexate—psoriatic arthritis	0.000597	0.000898	CcSEcCtD
Ipratropium bromide—Dizziness—Methotrexate—psoriatic arthritis	0.000577	0.000868	CcSEcCtD
Ipratropium bromide—Vomiting—Methotrexate—psoriatic arthritis	0.000554	0.000834	CcSEcCtD
Ipratropium bromide—Rash—Methotrexate—psoriatic arthritis	0.00055	0.000828	CcSEcCtD
Ipratropium bromide—Dermatitis—Methotrexate—psoriatic arthritis	0.000549	0.000827	CcSEcCtD
Ipratropium bromide—Headache—Methotrexate—psoriatic arthritis	0.000546	0.000822	CcSEcCtD
Ipratropium bromide—Nausea—Methotrexate—psoriatic arthritis	0.000518	0.00078	CcSEcCtD
